TANISHA HOOKER: Open Payments
NPI 1922449149 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,122 in 41 payments from 13 companies in 2025. Trend: 2023 $1,208 · 2024 $1,438 · 2025 $1,122
Food & beverage: $1,122
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $197 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $189 |
| Abbott Laboratories | 2 | $180 |
| AstraZeneca Pharmaceuticals LP | 6 | $141 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $93 |
| SCPHARMACEUTICALS INC. | 4 | $88 |
| PFIZER INC. | 4 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
Products named: JARDIANCE, CARDIOMEMS, CAMZYOS, LifeVest, FUROSCIX, VYNDAQEL, Kerendia, ELIQUIS.
Industry payments across GA — which companies pay providers there.
